Wise Young
About Wise Young
Data last updated:
Wise Young has 12 years in corporate governance. Holds Director role. Currently with 1 company, including Stemcyte India Therapeutics Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Stemcyte India Therapeutics Private Limited at ₹15.53 Cr (FY 2023).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Stemcyte India Therapeutics Private Limited U85100GJ2008FTC052859 | Director | 27 Mar 2014 | 2008 | ₹15.53 Cr (FY 2023) | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Wise Young
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Wise Young
Wise Young has 12 years in corporate governance. Holds Director role. Currently with 1 company, including Stemcyte India Therapeutics Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Stemcyte India Therapeutics Private Limited at ₹15.53 Cr (FY 2023).
Wise Young is associated with 1 company as Director, including Stemcyte India Therapeutics Private Limited (₹15.53 Cr).
Wise Young has expertise in General Business.
Wise Young has 12 years in corporate governance.
By reported revenue, the largest current company of Wise Young is Stemcyte India Therapeutics Private Limited, with revenue of ₹15.53 Cr (FY 2023).
Wise Young currently holds positions at 1 company: Stemcyte India Therapeutics Private Limited (₹15.53 Cr).